Lumedica, Inc.
PrivateLast Round
Debt
Dec 28, 2022
Total Funding Raised
$1.94M
Company Overview
Lumedica, Inc. operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Debt round in December 2022.
Lumedica, Inc. is a medical technology company that develops and manufactures affordable, portable optical coherence tomography (OCT) imaging systems for research, industrial, and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumedica, Inc. Comparables
Compare Lumedica, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Philophos | 86% | |
| Tishyas Medical Device Development Solutions | 84% | |
| Siloton | 81% |
For institutional investors. Book with your work email.
Lumedica, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 28, 2022 | ||||
| Grant | Jul 9, 2019 | ||||
| Grant | Jun 27, 2019 | ||||
| Seed | Jun 3, 2017 |
For institutional investors. Book with your work email.
Lumedica, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Eye Institute (NIH) | Grant |
| Luminate Accelerator | Grant |
| One North Carolina Small Business Program | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2022
$600K debt round completed.
- Jul 9, 2019
$1M grant received from the National Eye Institute (NIH).
For institutional investors. Book with your work email.
Lumedica, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lumedica, Inc.'s valuation, stock price, and market status.
Is Lumedica, Inc. a public or private company?
Lumedica, Inc. is a private company.
What is the current stock price of Lumedica, Inc.?
Lumedica, Inc. is a private company, so its shares have no public market price. Caplight tracks Lumedica, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lumedica, Inc. worth (valuation)?
Valuation information for Lumedica, Inc. is not publicly available.
Can I buy Lumedica, Inc. stock?
Lumedica, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lumedica, Inc.'s last funding round?
Lumedica, Inc.'s most recent funding round was Debt on December 28, 2022.
Who are the main investors in Lumedica, Inc.?
Key investors in Lumedica, Inc. include National Eye Institute (NIH), Luminate Accelerator, One North Carolina Small Business Program, National Institutes of Health (NIH).
Will Lumedica, Inc. IPO soon?
No public IPO plans have been announced for Lumedica, Inc..
How can I track Lumedica, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lumedica, Inc.'s shares on secondary markets.